Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Publications

EFFECTIVENESS OF OSTEOPOROSIS DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY

L. RODRÍGUREZ, J. POVEDA, C. CARBONELL-ABELLA, C. REYES, M. GIMÉNEZ, C. TORNÉ and D. MARTINEZ-LAGUNA
AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2024 Aug 1;

See more:
Association Between Anticoagulants and Interacting Drugs and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation: Case-Control Study in SIDIAP, Catalonia, Spain.

Giner-Soriano M, Carrasco-Ribelles LA, Fernández-García S, Castel Llobet J, Cereza García G and Morros R
CLINICAL THERAPEUTICS. 2025 Jul 1; . doi:10.1016/j.clinthera.2025.04.003; PMID:40348694

See more:
Incorporating sedentary behaviour for identifying risk of type 2 diabetes: Implications for primary care

F. ALÒS, A. PUIG-RIBERA, J. BORT-ROIG, E. CHIRVECHES-PÉREZ, A. BERENGUERA, C. MARTIN-CANTERA and M. COLOMER
Primary Care Diabetes. 2025 Jun 1; . doi:10.1016/j.pcd.2025.03.001; PMID:40068985

See more:
Weighting health-related estimates in the GCAT cohort and the general population of Catalonia

N. BLAY, L. CARRASCO-RIBELLES, X. FARRÉ, S. IRAOLA-GUZMÁN, M. DANÉS-CASTELLS, C. VIOLÁN and R. DE CID
Scientific Reports. 2025 May 16; . doi:10.1038/s41598-025-01284-9; PMID:40374680

See more:
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

L. MOLINOS-ALBERT, R. RUBIO, C. MARTÍN-PÉREZ, E. PRADENAS, C. TORRES, A. JIMÉNEZ, M. CANYELLES, M. VIDAL, D. BARRIOS, S. MARFIL, E. APARICIO, A. RAMÍREZ-MORROS, B. TRINITÉ, J. VIDAL-ALABALL, P. SANTAMARIA, P. SERRA, L. IZQUIERDO, R. AGUILAR, A. RUIZ-COMELLAS, J. BLANCO, C. DOBAÑO and G. MONCUNILL
Cell Reports. 2025 Apr 22; . doi:10.1016/j.celrep.2025.115498; PMID:40173043

See more:

Board of Trustees

Collaborators

Accreditations